[go: up one dir, main page]

AU2003275948A1 - Pharmaceutical composition comprising a tissue factor antagonist and protein c polypeptides - Google Patents

Pharmaceutical composition comprising a tissue factor antagonist and protein c polypeptides

Info

Publication number
AU2003275948A1
AU2003275948A1 AU2003275948A AU2003275948A AU2003275948A1 AU 2003275948 A1 AU2003275948 A1 AU 2003275948A1 AU 2003275948 A AU2003275948 A AU 2003275948A AU 2003275948 A AU2003275948 A AU 2003275948A AU 2003275948 A1 AU2003275948 A1 AU 2003275948A1
Authority
AU
Australia
Prior art keywords
polypeptides
protein
pharmaceutical composition
tissue factor
factor antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003275948A
Other versions
AU2003275948A8 (en
Inventor
Jakob Michael Back
Christian Meyer
Lars Christian Petersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU2003275948A8 publication Critical patent/AU2003275948A8/en
Publication of AU2003275948A1 publication Critical patent/AU2003275948A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003275948A 2002-11-06 2003-11-04 Pharmaceutical composition comprising a tissue factor antagonist and protein c polypeptides Abandoned AU2003275948A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200201709 2002-11-06
DKPA200201709 2002-11-06
PCT/DK2003/000752 WO2004041296A2 (en) 2002-11-06 2003-11-04 Pharmaceutical composition comprising a tissue factor antagonist and protein c polypeptides

Publications (2)

Publication Number Publication Date
AU2003275948A8 AU2003275948A8 (en) 2004-06-07
AU2003275948A1 true AU2003275948A1 (en) 2004-06-07

Family

ID=32309251

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003275948A Abandoned AU2003275948A1 (en) 2002-11-06 2003-11-04 Pharmaceutical composition comprising a tissue factor antagonist and protein c polypeptides

Country Status (2)

Country Link
AU (1) AU2003275948A1 (en)
WO (1) WO2004041296A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1587549A2 (en) * 2003-01-22 2005-10-26 Novo Nordisk A/S Radiolabelled tissue factor binding agent and the use thereof
UA109633C2 (en) 2008-12-09 2015-09-25 HUMAN ANTIBODY AGAINST TISSUE FACTOR
RS56599B1 (en) 2010-06-15 2018-02-28 Genmab As Human antibody drug conjugates against tissue factor
EP2869833B1 (en) * 2012-07-04 2018-04-04 ZZ Biotech LLC. Activated protein c for use in the treatment of inflammatory skin disorders
CN106488773B (en) 2014-04-16 2020-02-11 Zz生物技术有限责任公司 Use of APC analogues for wound healing
DK3137102T3 (en) 2014-04-16 2021-10-11 Zz Biotech Llc APC FOR USE FOR THE TREATMENT OF ABNORMAL CUTANE FORMATION
TWI841554B (en) 2018-03-21 2024-05-11 丹麥商珍美寶股份有限公司 Methods of treating cancer with a combination of a platinum-based agent and an anti-tissue factor antibody-drug conjugate
WO2019217455A1 (en) 2018-05-07 2019-11-14 Genmab A/S Methods of treating cancer with a combination of an anti-pd-1 antibody and an anti-tissue factor antibody-drug conjugate
TWI844571B (en) 2018-10-30 2024-06-11 丹麥商珍美寶股份有限公司 Methods of treating cancer with a combination of an anti-vegf antibody and an anti-tissue factor antibody-drug conjugate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1263943A1 (en) * 2000-02-11 2002-12-11 Eli Lilly & Company Protein c derivatives

Also Published As

Publication number Publication date
WO2004041296A2 (en) 2004-05-21
AU2003275948A8 (en) 2004-06-07
WO2004041296A3 (en) 2004-07-29

Similar Documents

Publication Publication Date Title
AU2003252478A1 (en) Ccr4 antagonist and medicinal use thereof
WO2004040000A9 (en) G protein coupled receptors and uses thereof
AU2003228809A1 (en) Kinase anchor protein muteins, peptides thereof, and related methods
AU2003234231A1 (en) New polyarylates for drug delivery and tissue engineering
AU2002337793A1 (en) Protein and peptide nanoarrays
AU2003222347A1 (en) Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof
IL163868A (en) Hemiasterlin derivatives and pharmaceutical compositions comprising them
AU2003289742A1 (en) Stable therapeutic proteins
AU2003234734A1 (en) Peptide antagonists of tgf-beta family members and therapeutic uses thereof
AU2003238039A1 (en) Nasal peptide pharmaceutical formulation
AU2003275948A1 (en) Pharmaceutical composition comprising a tissue factor antagonist and protein c polypeptides
PL369077A1 (en) Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides
AU2003276937A1 (en) Vegetable protein preparations and use thereof
AU2003226899A1 (en) Human diabetes-mediating proteins
AU2003222225A1 (en) Receptors and membrane-associated proteins
AU2003275947A1 (en) Pharmaceutical composition comprising a tissue factor antagonist and a blood glucose regulator
AU2003284597A1 (en) Apoptosis-associated protein and use thereof
HUP0401985A3 (en) Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides
SI1482967T1 (en) Pharmaceutical and cosmetic compositions comprising plgf-1
AU2003235887A1 (en) Bislactone derivative and use thereof in medicinal composition
EP1581250A4 (en) Oral formulations for proteins and polypeptides
AU2003280992A1 (en) Novel proteins and use thereof
AU2003220085A1 (en) Protein a compositions and methods of use
AU2003292774A1 (en) Novel proteins and use thereof
AU2003213933A1 (en) Purified polypeptides involved in protein synthesis and modification

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase